Result of EGM & Admission to trading

21 November 2012

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE

UNITED STATES, CANADA, JAPAN OR AUSTRALIA

Phorm Corporation Limited ("Phorm" or the "Company")

RESULT OF EXTRAORDINARY GENERAL MEETING AND ADMISSION TO TRADING

The Board of Phorm is pleased to announce that the resolution proposed to Shareholders at the Company's extraordinary general meeting held earlier today to grant authority to the Company's directors to issue and allot shares and other equity and convertible securities, was duly passed. This authority allows the Company to give effect to the Placing announced on 6 November 2012.

Application has been made for the Placing Shares to be admitted to trading on AIM and trading is expected to commence at 8:00 a.m. on 23 November 2012. Following admission of the Placing Shares, the total issued share capital of the Company will comprise 90,984,681 ordinary shares.

Terms capitalised in this announcement but not defined are as defined in the Placing announcement dated 6 November 2012.

For Enquiries

Phorm, Inc.

Mark Williams (analysts & investors) +44 20 7297 2326

Alex Laity (media) +44 20 7297 2710

Liberum Capital +44 20 3100 2222

(Nominated Advisor and Joint Broker)

Chris Bowman

Richard Bootle

Mirabaud Securities LLP +44 20 7321 2508

(Joint Broker)

Jason Woollard

Peter Krens

Hudson Sandler +44 20 7796 4133

Charlie Jack

Charlie Barker

- ends -

About Phorm

Phorm is a global personalisation technology company that makes content and advertising more relevant to the consumer. Phorm's innovative platform preserves user privacy and delivers a more interesting online experience.

Phorm's partners include leading Internet Service Providers (ISPs), Publishers, Ad Networks and Advertisers.

A Singapore incorporated company, Phorm (under a previous holding company) was admitted to the AIM market of the London Stock Exchange in 2004 and has over 140 employees and contractors.

For more information, please visit: www.phorm.com